Results
|
4161.
|
|
|
4162.
|
|
|
4163.
|
|
|
4164.
|
|
|
4165.
|
|
|
4166.
|
|
|
4167.
|
|
|
4168.
|
Sparse-data set analysis for irinotecan and SN-38 pharmacokinetics in cancer patients co-treated with cisplatin. [electronic resource] by
- Mathijssen, R H
- van Alphen, R J
- de Jonge, M J
- Verweij, J
- de Bruijn, P
- Loos, W J
- Nooter, K
- Vernillet, L
- Stoter, G
- Sparreboom, A
Producer: 19990601
In:
Anti-cancer drugs vol. 10
Availability: No items available.
|
|
4169.
|
|
|
4170.
|
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignancies. [electronic resource] by
- Goel, Sanjay
- Jhawer, Minaxi
- Rajdev, Lakshmi
- Hopkins, Una
- Fehn, Karen
- Baker, Cheryl
- Chun, Hoo G
- Makower, Della
- Landau, Leon
- Hoffman, Anthony
- Wadler, Scott
- Mani, Sridhar
Producer: 20021105
In:
American journal of clinical oncology vol. 25
Availability: No items available.
|
|
4171.
|
|
|
4172.
|
|
|
4173.
|
|
|
4174.
|
|
|
4175.
|
|
|
4176.
|
[Bevacizumab/irinotecan. An active treatment for recurrent high grade gliomas: preliminary results of an ANOCEF Multicenter Study]. [electronic resource] by
- Guiu, S
- Taillibert, S
- Chinot, O
- Taillandier, L
- Honnorat, J
- Dietrich, P Y
- Maire, J-P
- Guillamo, J S
- Guiu, B
- Catry-Thomas, I
- Capelle, F
- Thiebaut, A
- Cartalat-Carel, S
- Deville, C
- Fumoleau, P
- Desjardins, A
- Xuan, K Hoang
- Chauffert, B
Producer: 20081003
In:
Revue neurologique vol. 164
Availability: No items available.
|
|
4177.
|
Irinotecan hydrochloride (CPT-11) and cisplatin as first-line chemotherapy after initial surgery for ovarian clear cell adenocarcinoma. [electronic resource] by
- Takakura, Satoshi
- Saito, Motoaki
- Ueda, Kazu
- Motegi, Makoto
- Takao, Miho
- Yamada, Kyosuke
- Okamoto, Aikou
- Niimi, Shigeki
- Sasaki, Hiroshi
- Tanaka, Tadao
- Ochiai, Kazunori
Producer: 20080124
In:
International surgery vol. 92
Availability: No items available.
|
|
4178.
|
|
|
4179.
|
|
|
4180.
|
Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. [electronic resource] by
- Kopetz, Scott
- Hoff, Paulo M
- Morris, Jeffrey S
- Wolff, Robert A
- Eng, Cathy
- Glover, Katrina Y
- Adinin, Rosie
- Overman, Michael J
- Valero, Vincete
- Wen, Sijin
- Lieu, Christopher
- Yan, Shaoyu
- Tran, Hai T
- Ellis, Lee M
- Abbruzzese, James L
- Heymach, John V
Producer: 20100204
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28
Availability: No items available.
|